Triple-Negative Breast Cancer: Clear Answers for Newly Diagnosed
Triple-negative breast cancer: Stage I carries ~91% 5-year survival, but Stage IV drops to 12%. A gynecologic oncologist explains what pCR changes.
The Right Mammogram Age for Your Breast Cancer Risk Level
Breast cancer mammograms: ACS, USPSTF, and ACR now align on age 40 — but BRCA carriers start a decade earlier. Know your protocol.
What Your Breast Cancer Risk Factors Actually Mean for You
Breast cancer risk: BRCA1 mutation raises lifetime risk to 72%. Each daily drink adds 10% more — and a 20% Tyrer-Cuzick score changes your care plan.
Breast Cancer Types: Clear Answers for Newly Diagnosed Patients
Breast cancer types determine which drugs you get. TNBC needs pembrolizumab; HER2+ needs trastuzumab. Know your type before your first appointment.
Breast Cancer Survival Rates by Stage: A Trusted Physician Guide
Stage IV breast cancer survival: 31% in 2026 data. A board-certified gynecologic oncologist explains what each stage and subtype means for your prognosis.
Breast Cancer Stages, Clearly Explained by a Specialist
Breast cancer staging goes beyond a number. Your biomarker profile, TNM substage, and NCI SEER 2026 survival data shape your actual prognosis.
Recognizing Breast Cancer Symptoms Before They Progress
Breast cancer symptoms — most of them painless — have a 99% 5-year survival rate when localized. Here's what an oncologist checks first.
Breast Cancer Stages and Survival: What You Need to Know First
Breast cancer stage guides treatment—but receptor subtype changes the plan. An oncologist explains all four treatment pathways using NCCN 2026.
Trusted Palliative Care Guide for Lung Cancer Patients
Palliative care for lung cancer isn't hospice — NCCN 2026 recommends concurrent enrollment from diagnosis. An oncologist explains when to start.
Liquid Biopsy for Lung Cancer: The Clear Clinical Answer on ctDNA
Liquid biopsy detects EGFR and T790M mutations from a blood draw—no surgery. A board-certified oncologist explains when NCCN 2026 endorses it over tissue biopsy.